Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)

  1. Peeters, M.
  2. Price, T.
  3. Hotko, Y.
  4. Cervantes, A.
  5. Ducreux, M.
  6. Andre, T.
  7. Chan, E.
  8. Lordick, F.
  9. Rong, A.
  10. Gansert, J.
Zeitschrift:
EJC SUPPLEMENTS

ISSN: 1359-6349,  1878-1217

Datum der Publikation: 2009

Ausgabe: 7

Nummer: 3

Seiten: 10-10

Kongress: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Art: Konferenz-Beitrag

DOI: 10.1016/S1359-6349(09)72049-X GOOGLE SCHOLAR
Fuente de los datos: WoS